Por: ABC7 World May 13, 2023
, without many treatment options.Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during menopause.The drug, a pill taken once a day, is hormone-free, which makes it promising for women who cannot take hormone treatment because of other underlying health concerns, such as a prior history of strokes, heart attacks or blood... + full article
Time USA Health May 16, 2023
WASHINGTON — U.S. health regulators on Friday approved a new type of drug for women dealing with uncomfortable hot flashes caused by menopause. The Food and Drug Administration approved the once-a-day pill from Astellas Pharma to treat moderate-to-severe symptoms, which can... + más
FDA approves first-of-its-kind drug to treat hot flashes | ABC News
Cannabis Can Help Manage Menopause, Study Suggests | Forbes
ABC News USA Life May 13, 2023
Women have suffered for centuries with hot flashes, one of the , without many treatment options.Now, the U.S. Food and Drug Administration has approved a first-of-its-kind drug, fezolinetant, sold under the brand name Veozah, to treat moderate to severe hot flashes during... + más
FDA approves first-of-its-kind drug to treat hot flashes | ABC7
FDA approves drug called Veozah to treat hot flashes resulting from menopause | CBS News
WPTV USA Nation May 13, 2023
When a woman gets older, her period will eventually stop — a natural menopausal transition that can leave many women struggling with symptoms for years.One of the most common symptoms are hot flashes, and there haven't been many treatment options — until now.On Friday,... + más
CBS News USA Politics May 12, 2023
The Food and Drug Administration announced Friday it has approved a new kind of drug to treat moderate to severe hot flashes caused by , which could offer relief to millions of women who do not want to take hormone therapy to treat their symptoms.Drugmaker Astellas says the... + más
Time USA Health April 12, 2023
Now that a Texas judge has ruled that the U.S. Food and Drug Administration (FDA)’s , what happens to the supply of the drug? The judge gave the Department of Justice (DOJ), which represents the FDA, until Apr. 14 to file an appeal before the suspension of the drug takes... + más
What Are the Duties of A Trustee? | Forbes
NFL Week 17 playoff picture and clinching scenarios: Bucs win NFC South; Giants clinch wild card | ESPN
Politico USA Health December 30, 2022
The FDA’s collaboration with Biogen, the maker of a controversial Alzheimer’s drug, before it granted the product accelerated approval was “atypical” and ran afoul of the agency’s protocol for documenting interactions with drug companies, according to a joint House... + más
Alzheimer's drug approval by FDA 'rife with irregularities,' probe finds | Los Angeles Times
Probe: Alzheimer's drug approval 'rife with irregularities' | ABC News
ABC News USA Health September 30, 2022
WASHINGTON -- A much-debated drug for Lou Gehrig’s disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.Amylyx Pharmaceuticals said the Food and... + más
Highly debated Amylyx Pharmaceuticals ALS drug wins FDA approval | New York Post
ALS drug wins FDA approval despite questionable data | WPLG Local 10
About iurex | Privacy Policy | Disclaimer |